secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANNKIND CORP (MNKD)
CIK:        0000899460
Form:       8-K
Filed at:   2023-12-27T23:59:59+00:00
Accession:  0001193125-23-303995
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MannKind restructures Amphastar supply deal: lowers annual commitments, adds capacity fees
--------------------------------------------------------------------------------

- Prior total purchase commitments of €58.7M for 2024-27 replaced; new commitments for 2024 = €2.9M, 2025 = €1.5M.
- Capacity fee introduced: €2M/year in Year 1 of new supply, decreasing to €500k/year in Years 6-9.
- Term extended to later of Dec 31, 2035 or completion of purchase commitments.
- Amendment accommodates change in source of inclusion bodies (insulin intermediate) to Amphastar-manufactured.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/899460/000119312523303995/0001193125-23-303995-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/899460/000119312523303995/d57247d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-303995

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer